Radiology Partners unit Mosaic petitions FDA on imaging AI regulation
Mosaic, a unit of Radiology Partners, has filed a petition with the FDA seeking regulatory action on the use of artificial intelligence in medical imaging. The move signals growing industry pressure for clearer federal oversight of AI tools used in radiology.
Why this matters: AI is already reading medical scans in real hospitals. The question of who sets the rules for that — and what happens when it gets a diagnosis wrong — is not settled. A petition from an industry player means companies want regulatory clarity, which can be good or self-serving depending on what they are asking for. Patients have no easy way to know when AI is involved in reading their imaging, or what standards that AI was held to before it was used on them.
Who should care: AI governance · Lawyers · Administrators · Compliance · General readers · Policy
This summary is AI-assisted and may contain errors. It is an original briefing to help you gauge significance quickly — not a reproduction of the source. Always read the linked original before relying on it. See our methodology.